Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts
Michael J. Hassett(Harvard University), Jane C. Weeks(King Edward Memorial Hospital), Nathan Taback(Ontario Institute for Cancer Research), Debra P. Ritzwoller(Kaiser Permanente), Joan L. Warren(American Cancer Society), Deborah Schrag(Dana-Farber Brigham Cancer Center), Mark C. Hornbrook(Kaiser Permanente Center for Health Research), Gladys Ting(Dana-Farber Cancer Institute), Angel M. Cronin, Nikki M. Carroll(Kaiser Permanente)
Cited by 122
Related Papers
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Diagnosis and Treatment of Metastatic Colorectal Cancer
|JAMA|2021|2.6k